These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6084898)

  • 1. [Serum nucleases as nonspecific antiviral factors and their role in artificial anti-influenza immunity].
    Maksimovich MB
    Vopr Virusol; 1984; 29(6):682-7. PubMed ID: 6084898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influenza inhibitor of the host serum RNAse].
    Maksimovich MB
    Vopr Virusol; 1986; 31(5):562-7. PubMed ID: 3798907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulating action of levamisole in its combined use with influenza vaccines].
    Obrosova-Serova NP; Schastnyĭ EI; Kupriashina LM; Slepushkin AN; Shenderovich SF
    Vopr Virusol; 1984; 29(4):454-9. PubMed ID: 6208690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibitor participation in the regulation of serum RNAse activity in the formation of immunity against influenza].
    Parfenova MS; Maksimovich MB; Bukovetskiĭ SI; Tishechkina VA; Lisovaia SP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):37-41. PubMed ID: 948958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant.
    Zanvit P; Havlícková M; Tácner J; Novotná O; Jirkovská M; Cechová D; Julák J; Sterzl I; Prokesová L
    Immunol Lett; 2008 Jan; 115(2):144-52. PubMed ID: 18160106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of rabbits with DNase I produces polyclonal antibodies with DNase and RNase activities.
    Krasnorutskii MA; Buneva VN; Nevinsky GA
    J Mol Recognit; 2008; 21(4):233-42. PubMed ID: 18446884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody functional activity in immunization with influenza vaccines].
    Naĭkhin AN; Artem'eva SA; Ermachenko TA; Vybornykh EN; Kustikova IuG; Doroshenko EV; Katorgina LG; Denisov GM; Kim TN
    Vopr Virusol; 1993; 38(5):204-7. PubMed ID: 8284916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cross protection in mice immunized with different anti-influenza preparations].
    Rudenko LG; Sosunov AV; Zykov MP
    Vopr Virusol; 1981; (6):706-9. PubMed ID: 7336695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homologous and heterologous antibody induction in influenzal infection and immunization].
    Rudenko LG; Rafaél'skaia TI; Nesterenko LS
    Vopr Virusol; 1977; (4):477-80. PubMed ID: 579009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.
    Ennis FA
    J Infect Dis; 1973 Jun; 127(6):632-8. PubMed ID: 4350518
    [No Abstract]   [Full Text] [Related]  

  • 16. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus.
    Saha S; Yoshida S; Ohba K; Matsui K; Matsuda T; Takeshita F; Umeda K; Tamura Y; Okuda K; Klinman D; Xin KQ; Okuda K
    Virology; 2006 Oct; 354(1):48-57. PubMed ID: 16945400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune control of herpes simplex virus infections.
    Ennis FA; Wells M
    Cancer Res; 1974 May; 34(5):1140-5. PubMed ID: 4546304
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.
    Nguyen HH; Moldoveanu Z; Novak MJ; van Ginkel FW; Ban E; Kiyono H; McGhee JR; Mestecky J
    Virology; 1999 Feb; 254(1):50-60. PubMed ID: 9927573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the single radial complement fixation (SRC-fix) test.
    Niwayama S; Sato S; Ochiai H; Mutoda S; Iwase I; Hayashi K
    J Virol Methods; 1981 Apr; 2(5):261-8. PubMed ID: 6262349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.